#China #Qingdao #Sustainability Report #Global Healthcare #Haier Biomedical

Haier Biomedical's 2025 Sustainability Report

Haier Biomedical, a leader in life sciences and medical solutions, recently released its 2025 Sustainability Report, showcasing the company's unwavering commitment to environmental, social, and governance (ESG) initiatives. As a pioneer in the industry, Haier Biomedical has made significant strides in promoting safer, greener, and more accessible healthcare solutions on a global scale.

Commitment to Sustainable Development Goals

The report emphasizes Haier Biomedical's adherence to the United Nations Sustainable Development Goals (SDGs), aligning its operations with all 17 goals under its LIFE sustainability framework, which stands for Leadership, Integrity, Future, and Ecosystem. By implementing innovative technologies and localized strategies, the company enhances public health initiatives worldwide. This includes strengthening service networks, advancing scientific research, and driving sustainable growth through low-carbon solutions.

Chairwoman Tan Lixia remarked, "In 2025, we achieved three strategic leaps from products to scenarios, from China to the world, and from a single industry to a platform ecosystem. Guided by our philosophy of 'Intelligent of Life Science,' we continue to foster low-carbon innovation and global health accessibility."

Research and Development Priorities

Haier Biomedical places a strong emphasis on research and development, which accounts for approximately 28.56% of its workforce. The company has implemented a three-tier R&D management structure that balances resources to drive innovation and accelerate new product development. The results are impressive: R&D investment reached 323 million yuan (approximately USD 47.25 million), while the number of new invention patents increased by 50% year-on-year, representing 73% of their portfolio. Furthermore, Haier Biomedical holds 428 software copyrights and has earned 51 awards for science and technology.

The company integrates artificial intelligence (AI) into its R&D processes, launching several advanced solutions. Noteworthy innovations include the "AI+ Safety Cabinet," boasting 99% recognition accuracy for medicine vials, the automated chemotherapy preparation robot, and a Fully Automated Cell Culture Workstation that enhances manufacturing standardization and reduces labor costs.

Recognition and Innovations

These groundbreaking advancements earned Haier Biomedical accolades, including a second prize at the 2025 Qingdao Science and Technology Progress Award, as well as a first prize at the Shandong Provincial Science and Technology Progress Award. The company's initiatives in quality management further strengthen its operational efficiency. By incorporating digital technologies throughout its production journey, Haier ensures smarter quality management processes, which enhance product reliability and reduce risks.

Transforming Manufacturing through Technology

The adoption of smart IoT technology within Haier Biomedical’s manufacturing processes allows the company to maintain precise control and real-time monitoring of quality. This automation caters to quality assurance throughout the product lifecycle. The firm also promotes energy-saving practices through innovative techniques such as Eco-Drive technology and eco-friendly packaging. In the reporting period, Haier obtained 122 energy-saving certificates for various product models and expanded its ENERGY STAR certification.

In collaboration with global research institutions, including the University of Liverpool and Eurofins, Haier Biomedical is leveraging low-carbon technologies to support research while minimizing environmental impacts.

Commitment to Social Responsibility

Haier Biomedical's dedication extends beyond technology and innovation. The company actively engages in community aid, donating over 1.4 million yuan (about USD 205,697.8) to support various social welfare initiatives. As a partner of GAVI, Haier's efforts to improve global immunization underscore its commitment to child health and well-being worldwide.

Moreover, Haier is focused on creating a diverse and inclusive workplace and has introduced initiatives to support employee growth and equity share programs as part of its medium- to long-term plans.

Future Outlook

Moving forward, Haier Biomedical is set to continue its transformative journey by prioritizing digital capabilities and global expansion within its platform-driven ecosystem. The ongoing advancements in life sciences and healthcare technology position the company as a frontrunner in enhancing global patient well-being.

For further details about Haier Biomedical and its initiatives, visit Haier Medical.